Patents by Inventor Haa-Yung Lee

Haa-Yung Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
    Patent number: 7985729
    Abstract: The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof.
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: July 26, 2011
    Assignee: House Research Institute
    Inventors: David J. Lim, Haa-Yung Lee, Paul Webster, Ali Andalibi, Jian-Dong Li, Tomas Ganz, Kiweon Cha
  • USE OF ANITMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
    Publication number: 20100204447
    Abstract: The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof.
    Type: Application
    Filed: April 21, 2010
    Publication date: August 12, 2010
    Applicant: HOUSE EAR INSTITUTE
    Inventors: DAVID J. LIM, HAA-YUNG LEE, PAUL WEBSTER, ALI ANDALIBI, JIAN-DONG LI, TOMAS GANZ, KIWEON CHA
  • USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
    Publication number: 20090023893
    Abstract: The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof.
    Type: Application
    Filed: July 16, 2008
    Publication date: January 22, 2009
    Applicant: House Ear Institute
    Inventors: David J. Lim, Haa-Yung Lee, Paul Webster, Ali Andalibi, Jian-Dong Li, Tomas Ganz, Kiweon Cha
  • Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
    Patent number: 7338936
    Abstract: The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: March 4, 2008
    Assignee: House Ear Institute
    Inventors: David J. Lim, Haa-Yung Lee, Paul Webster, Ali Andalibi, Jian-Dong Li, Tomas Ganz, Kiweon Cha
  • USE OF ANTIMICROBIAL PROTEINS AND PEPTIDES FOR THE TREATMENT OF OTITIS MEDIA AND PARANASAL SINUSITIS
    Publication number: 20070207963
    Abstract: The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof.
    Type: Application
    Filed: May 18, 2007
    Publication date: September 6, 2007
    Applicant: HOUSE EAR INSTITUTE
    Inventors: David Lim, Haa-Yung Lee, Paul Webster, Ali Andalibi, Jian-Dong Li, Tomas Ganz, Kiweon Cha
  • Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
    Patent number: 7060674
    Abstract: Disclosed herein is a composition and a method for the treatment of otitis media and paranasal sinusitis using human defensins, lysozyme and/or lactoferrin as a new class of non-antibiotic antimicrobials. From studies of otitis media and paranasal sinusitis, it was observed that certain innate immune modulators were important in the bodies response to the infection. Therefore, these innate immune modulators, lysozyme, lactoferrin, and defensins were tested for use as a non-antibiotic treatment for infection, particularly infections such as otitis media and sinusitis.
    Type: Grant
    Filed: April 6, 2004
    Date of Patent: June 13, 2006
    Assignee: House Ear Institute
    Inventors: David J. Lim, Haa-Yung Lee, Paul Webster, Ali Andalibi, Jian-Dong Li, Tomas Ganz
  • Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
    Publication number: 20060034820
    Abstract: The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof.
    Type: Application
    Filed: October 22, 2004
    Publication date: February 16, 2006
    Inventors: David Lim, Haa-Yung Lee, Paul Webster, Ali Andalibi, Jian-Dong Li, Tomas Ganz, Kiweon Cha
  • Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
    Publication number: 20040265296
    Abstract: Disclosed herein is a composition and a method for the treatment of otitis media and paranasal sinusitis using human defensins, lysozyme and/or lactoferrin as a new class of non-antibiotic antimicrobials. From studies of otitis media and paranasal sinusitis, it was observed that certain innate immune modulators were important in the bodies response to the infection. Therefore, these innate immune modulators, lysozyme, lactoferrin, and defensins were tested for use as a non-antibiotic treatment for infection, particularly infections such as otitis media and sinusitis.
    Type: Application
    Filed: April 6, 2004
    Publication date: December 30, 2004
    Inventors: David J. Lim, Haa-Yung Lee, Paul Webster, Ali Andalibi, Jian-Dong Li, Tomas Ganz
  • Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
    Patent number: 6716813
    Abstract: Disclosed herein is a method for the treatment of otitis media and paranasal sinusitis using human defensins, lysozyme and/or lactoferrin as a new class of non-antibiotic antimicrobials. From studies of otitis media and paranasal sinusitis, it was observed that certain innate immune modulators were important in the bodies response to the infection. Therefore, these innate immune modulators, lysozyme, lactoferrin and defensins, were tested for use as a non-antibiotic treatment for infection, particularly infections such as otitis media and sinusitis.
    Type: Grant
    Filed: November 27, 2001
    Date of Patent: April 6, 2004
    Assignee: House Ear Institute
    Inventors: David J. Lim, Haa-Yung Lee, Paul Webster, Ali Andalibi, Jian-Dong Li, Tomas Ganz
  • Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
    Publication number: 20020141986
    Abstract: Disclosed herein is a composition and a method for the treatment of otitis media and paranasal sinusitis using human defensins, lysozyme and/or lactoferrin as a new class of non-antibiotic antimicrobials. From studies of otitis media and paranasal sinusitis, it was observed that certain innate immune modulators were important in the bodies response to the infection. Therefore, these innate immune modulators, lysozyme, lactoferrin, and defensins were tested for use as a non-antibiotic treatment for infection, particularly infections such as otitis media and sinusitis.
    Type: Application
    Filed: November 27, 2001
    Publication date: October 3, 2002
    Inventors: David J. Lim, Haa-Yung Lee, Paul Webster, Ali Andalibi, Jian-Dong Li, Tomas Ganz